1 jun

Mediq, international supplier of medical devices and pharmaceuticals, has finalized the acquisition of Diabetes Specialty Centre (DSC). Acquiring DSC strengthens the position of Byram Healthcare (United States' subsidiary of Mediq) number 4 position in this large but fragmented market.

DSC delivers insulin pumps, continuous glucose monitors and the related supplies to frequent-user, insulin-dependent diabetics. Mediq has been active in the US through Byram Healthcare since 2008.
Mediq announced this acquisition in a press release on 23 April 2012. In 2010 the turnover of DSC was $ 26 million (€ 19 million). The DSC results will be consolidated as of per today.

Download PDF  (101 KB)
E-mail Alert

To have press releases sent directly to your email address, please subscribe to the email alert service.



Contact

Mediq
Hertogswetering 159
3543 AS Utrecht
the Netherlands 
T +31 30 282 19 11
F +31 30 289 66 50

Investors
Catrien van Buttingha Wichers
Corporate Communication Director
T +31 30 2821609
M +31 6 5339 3665 
catrien.van.buttingha@mediq.com

Press
Ynte Hoekstra, Manager Corporate Communications
T +31 (0)30 282 1061
M +31 (0)6 2219 7204 
ynte.hoekstra@mediq.com

Annegees van Linge (on maternity leave)
annegees.van.linge@mediq.com

distributed by